Skip to search.
 FTSE 100 Up 1.34%

VIVUS Inc. (VVUS)

-NasdaqGS
2.33 Down 0.03(1.27%) 20:17 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:2.36
Open:2.37
Bid:2.31 x 6600
Ask:2.32 x 3400
1y Target Est:4.50
Beta:1.76
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:2.30 - 2.39
52wk Range:2.22 - 5.45
Volume:695,764
Avg Vol (3m):1,065,830
Market Cap:241.89m
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VVUSDown 1.27%241.89m
LLYUp 1.40%89.65b
GSKUp 1.02%101.61b
PFEUp 0.54%207.58b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.84
Quarterly EPS Est (Jun-15) :-0.23
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-3.74

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback